PVSG and WHO bone marrow evaluation in 90 essential thrombocythaemia (ET) patients treated with Peg interferon A2b. Preliminary results

    Research output: Contribution to conferenceOther

    Original languageUndefined/Unknown
    PagesP661-
    Publication statusPublished - 2005

    Cite this